tag:blogger.com,1999:blog-7857054149675424609.post8466310287054409195..comments2024-02-24T08:58:08.581+00:00Comments on RNAi Therapeutics: Nature Publishes Reassuring Study by Alnylam on the in vivo Delivery of siRNAs and their Effect on the Endogenous microRNA PathwayDirk Hausseckerhttp://www.blogger.com/profile/18320439857875629714noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-7857054149675424609.post-71037020780946547302007-10-15T17:10:00.000+00:002007-10-15T17:10:00.000+00:00Good questions. Please understand, however, that ...Good questions. Please understand, however, that I would rather not comment on this issue since this involves my PI, Mark Kay, and I would not like to interfere here.Dirk Hausseckerhttps://www.blogger.com/profile/18320439857875629714noreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-62244137987038761422007-09-30T08:53:00.000+00:002007-09-30T08:53:00.000+00:00Following your blog on RNAi and microRNA. Just wo...Following your blog on RNAi and microRNA. Just wondering if you have much exposure to the Australian CSIRO work on ddRNA/shRNA and Hellsgate delivery vectors?<BR/><BR/>As you are at Stanford - I expect you are well aware of G Kay and the HCV therapy being readied for IND by Tacere?Enumeratehttps://www.blogger.com/profile/16016110541836597452noreply@blogger.com